LINDSEY BROWN: Open Payments
NPI 1689330029 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 20 payments from 8 companies in 2025. Trend: 2023 $149 · 2024 $485 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Shionogi Inc | 8 | $170 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $97 |
| ABBVIE INC. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| PFIZER INC. | 1 | $22 |
| Route 92 Medical, Inc. | 1 | $19 |
Products named: Fetroja, XIFAXAN, ELIQUIS, DALVANCE, ZERBAXA, VPRIV.
Industry payments across KY — which companies pay providers there.
